All of Life Screening ‘s ultrasound screenings are painless and non-invasive, as is their EKG (electrocardiogram) for atrial fibrillation (AFib), also known as an irregular heartbeat. Even their blood screenings just need finger-prick plus a few drops of blood.
Also, their screenings need little or even no preparation. Some screening requires several fasting hours; others just require short sleeves or loose clothing. Life Screening tries to make it easier for their clients to manage their health. Here are the do’s and don’ts before your screening.
Atrial fibrillation (stroke)
• You should put on a two-piece outfit that’s comfortable and made up of loose clothing.
• You should not wear oil or lotion
• Make sure you switch off your phone
• You shouldn’t wear a watch
• You should not wear pantyhose
Carotid artery disease (Stroke)
• You should put on a shirt that’s open at the collar as well as short-sleeved. Don’t wear a turtleneck.
AAA (Abdominal aortic aneurysm)
• You should wear a two-piece outfit that’s comfortable and made up of loose clothing.
• You should fast for four hours before your screening. Also, make sure that the meal you take four hours before screening, is half of what you usually eat of non gassy food. If you feel thirsty during the fasting period, you can take a half cup of tea or coffee plus a reasonable amount of water.
• If you have diabetes and you aren’t comfortable with fasting for four hours, strictly take a diabetic meal.
• If you should take medication, then take it as prescribed.
6 for Life Package
• You should put on a shirt with short sleeves or one with sleeves easily rolled up because of blood pressure cuffs.
• You should fast for eight hours before your screening to get accurate results.
Bone mineral density or BMD (osteoporosis risk)
• You should not wear pantyhose
For Elevated liver enzymes (ALT/AST)
• For this screening, you don’t need to do anything in advance
For Glucose (Diabetes mellitus type 2)
• You should fast for eight hours before your screening.
Learn More: www.lifelinescreeningresearch.com/
Mikhail Blagosklonny is one of the known modern scientists that have put much effort in the field of research studying age and cancer. He is one of the oncology experts that plays a critical role in the Institute of Roswell. He started his debut in the field of research in the institute from the year 2009. He gains the skills in the sphere of science from the First Pavlov State Medical University where he had MD in Internal Medicine.Mikhail Blagosklonny the furthered his studies as a Ph.D. graduate from the Experimental Medicine and Medical College. This effort has put him at the required niche and placed him as the associate professor at the New York Medical College. He further made an extent in his ardent area of concern as the superior scientist at the research institute called Ordway Research Institute. He has earned the excellent experience from the various areas that he has had a chance to serve in.
Mikhail Blagosklonny great effort in the research matters has placed him among the Cell Death and Differentiation editorial board and decision making of the Institute. This has put him forward in putting his theory relating to the TOR in the association of the age and cancer and suggested the use of Rapamycin as the best to heal the disease. Out of the substantiation of his research, he has become a great supporter of the Rapamycin in the cancers treatment. He campaigns for the use of in the sense that it stabilizes the cancerous cells and maintains the state of the healthy cells at it was as oppose to the other means of treatments such as chemotherapy. The primary achievement of the research Mikhail has made the range that marks the cellular and molecular biology.The interest of Mikhail in the Oncology has grounded the best ground that will level the benefit of the scientist in the field of research.
To him, there is the possibility of curing cancer, and he believes that there is also there is a need to create a society that is free from diseases. He has played a humanitarian role in leading another researcher to carry out different research. This has forced him to put most of the finding in his publications and books to discuss the aging hyper function theory. Additionally, the cell cyclotherapy matters are intensely discussed in the publication and also the procedures on how to use the Rapamycin. In his books and articles, he emphasizes that cancers treatment is possible as any other disease.The commitment to the research about cancer has earned him to be the best researcher in the universe. The interest of Mikhail in factoring in the hope in the community is by putting off cancer. Also, Mikhail is also the PLOS ONE editor, and his dedication has placed him at the required position in the world of research. The in-depth research has further extended the signal on the pathway on utilizing the Rapamycin as cancer treatment medicine in the world.
Numerous techniques have come up to reduce the effects that aging has on the body. One of the prominent ways has been through the process of increasing cellular rejuvenation. There are various ways that have been proven to boost cellular rejuvenation including using nutrition. The process basically entails the regulation of dieting and nutrition. Oncotarget was able to prove the relationship between these two complex components in reducing the effects of aging. They pointed out that dietary energy regulation coupled with nutrition is able to even extend the lifespan of any particular person.
Dietary energy regulation is implemented through diet or calorie restrictions which mean the same thing with minimal differences. Calorie Restriction is achieved through the reduction of energy concentration. This can only be done by changing up the overall composition of the diet. However, Dietary Restrictions seeks to reduce the amount of food per serving. Since the use of Dietary Restriction is not as involving as Calorie Restriction, it is normally recommended for the purpose of increasing the lifespan.
When broaching the subject of dietary restrictions, mTOR functioning cannot fail to come up. This is due to the fact that DR treatments are majorly responsible for the elimination of the anabolic pathways that nutrients normally use. This results in the intensified cell rejuvenation and extension of life which are optimized through the restriction of mTOR Functioning. This activity has been known to hinder the cell rejuvenation process thereby exuding the body from the benefits that come from dietary restrictions. mTOR extensive activities also cause cell deprivation and rapid aging owing to the continual distribution of nutrients.
A Closer Glance at Oncotarget
Oncotarget is your conventional American journal that is optimized for authors who want to boost the impression and reach of their publications. The journal basically focuses on the publication of case studies, books, research papers, reviews, and editorials. These materials highlight on issues about pathology, oncology, endocrinology, and diseases related to age.Through the editors, Andrei V Gudkov and Mikhail Blagosklonny, the main objective of this journal is to make the conclusive findings from these research avenues available.
Foresite Capital is a health care and growth equity firm that has chosen to announce the entry of another partner, Molly He. Molly is a former senior director at Illumina and she brings with her more than a decade and a half experience in the Pharmaceutical industry with a special focus on genomic research and development.
According to Jim Tananbaum, Dr. He is one of the most respectable and reputable science researchers in the next generation sequencing field. Because of this, Jim, who is the CEO and MD of Foresite Capital is thrilled and excited to welcome her on board. It is believed that her remarkable leadership record of accomplishment and excellent result delivery in the genomic and drug development industry will be an invaluable resource to the company. She will serve as the much-needed resources for the expansion and diversification of the company’s portfolio, which is necessary for its growth and transformation.Sourced Info: Drewaltizer.com
As one of the senior directors at Illumina, Dr. He was the company’s global protein reagent innovation and improvements. Before then she was the head of protein sciences at the Pacific Biosciences where her responsibility was developing protein reagents for the company’s single molecule real time chemistry sequencing. She had spent ten years early in her career in the pharmaceutical industry focusing on structural based designed antibodies as well as small-molecule drugs that targeted immune diseases as well as cancer. Click here: https://ideamensch.com/jim-tananbaum/
Dr. He is a Biochemistry degree holder from Nankai University and also has a PhD in Biophysics from the university of California, Los Angeles. She has authored more than 20 published papers and is a patent holder of more than 20 patent applications. She has been issued patents in the field of next generation sequencing as well as personalized medicine.
About Jim Tannanbaum
Jim Tannanbaum was named the CEO and managing director of Foresite capital early this year. Jim has been named in three consecutive years as the best tech investor in the Forbes Midas list.
Dr. Jim is a leader in this industry with two and a half decades of offering innovative solutions for the health care. He graduated from Yale with BS/BSEE degrees and an MBA and MD from Harvard. He also has an M.S from MIT. He has everything it takes to excel in this industry. More details can be found on LinkedIn.com.
See more: http://pelotontherapeutics.com/bod-jim-tananbaum/